A safety assessment of diaspirin cross-linked hemoglobin (DCLHb) in the treatment of hemorrhagic, hypovolemic shock.

Przybelski, R J; Daily, E K; Micheels, J; Sloan, E; Mols, P; Corne, L; Koenigsberg, M D; Bickell, W H; Thompson, D R; Harviel, J D; Cohn, S M

Przybelski, R J; Daily, E K; Micheels, J; Sloan, E; Mols, P; Corne, L; Koenigsberg, M D; Bickell, W H; Thompson, D R; Harviel, J D; Cohn, S M.

Affiliation

Przybelski RJ; Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, USA.

Prehosp Disaster Med ; 14(4): 251-64, 1999.

Article in En | MEDLINE | ID: mdl-10915412

Subject(s)

Aspirin/analogs & derivatives; Blood Substitutes/therapeutic use; Hemoglobins/therapeutic use; Shock, Hemorrhagic/therapy; Adult; Analysis of Variance; Aspirin/therapeutic use; Double-Blind Method; Female; Humans; Male; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Shock, Hemorrhagic / Blood Substitutes / Hemoglobins / Aspirin Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Prehosp Disaster Med Journal subject: MEDICINA DE EMERGENCIA Year: 1999 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links